A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
BACKGROUND and AIM In patients with congenital adrenal hyperplasia (CAH), final height may be compromised due to high levels of androgens. This condition is more prominent in patients incompatible with treatment or in undertreated patients. Increased adrenal androgen production causes an alteration in bone age with loss of growth potential. Moreover, central precocious puberty (CPP) might be seen in those patients as a result of stimulation of the hypothalamic-pituitary axis. Gonadotropindoi:10.1530/endoabs.32.p802 fatcat:nlm7errbl5ah7b4kkrgzlcwvsa